Alto Neuroscience Inc. (ANRO)
4.31
-0.13 (-2.93%)
At close: Jan 15, 2025, 3:59 PM
4.30
-0.23%
After-hours Jan 15, 2025, 04:10 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 |
| PE Ratio | -15.33 | -19.1 | -57.62 |
| PS Ratio | n/a | n/a | 2.52K |
| PB Ratio | -7.76 | -13.78 | -42.43 |
| P/FCF Ratio | -16.41 | -25.06 | -53.25 |
| P/OCF Ratio | -16.64 | -25.96 | -57.16 |
| OCF/S Ratio | n/a | n/a | -44.1 |
| Debt / Equity Ratio | -0.14 | -2.14 | -3.06 |
| Quick Ratio | 15.22 | 8.85 | 15.30 |
| Current Ratio | 15.22 | 8.85 | 15.30 |
| Asset Turnover | n/a | n/a | 0.01 |
| Interest Coverage | -27.6 | n/a | n/a |
| Return on Equity (ROE) | 0.51 | 0.72 | 0.74 |
| Return on Assets (ROA) | -0.42 | -0.54 | -0.32 |
| Return on Capital (ROIC) | -0.47 | -0.64 | -0.45 |
| Dividend Yield | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a |
| Gross Profit Margin | n/a | n/a | 30.95% |
| Net Profit Margin | n/a | n/a | -4.37K% |
| Pretax Profit Margin | n/a | n/a | -4.37K% |
| Operating Profit Margin | n/a | n/a | -5.74K% |
| FCF Margin | n/a | n/a | -4.73K% |
| EBITDA Margin | n/a | n/a | -4.31K% |